Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | DHFR | P00374 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20926267 | 0.96 | PDK2 (0.40) | CYP2A6PDK2ALDH1A1DHFRKDM4E | |
| SCHEMBL20926273 | 0.89 | CYP2A6 (0.36) | CYP2A6PDK2ALDH1A1KDM4EMAPT | |
| SCHEMBL23273215 | 0.88 | PDK2 (0.37) | CYP2A6PDK2ALDH1A1HPGDCYP1A2 | |
| SCHEMBL20222320 | 0.88 | PDK2 (0.37) | CYP2A6PDK2ALDH1A1HPGDCYP1A2 | |
| SCHEMBL30803800 | 0.88 | PDK2 (0.37) | CYP2A6PDK2ALDH1A1HPGDCYP1A2 | |
| SCHEMBL20222319 | 0.87 | PDK2 (0.36) | CYP2A6PDK2ALDH1A1HPGDCYP1A2 | |
| SCHEMBL25883223 | 0.86 | PDK2 (0.36) | CYP2A6PDK2AHR | |
| SCHEMBL22337257 | 0.85 | PDK2 (0.36) | CYP2A6PDK2ALDH1A1HPGDCYP1A2 | |
| SCHEMBL22337131 | 0.83 | AHR (0.35) | CYP2A6PDK2ALDH1A1HPGDCYP1A2 | |
| SCHEMBL16674461 | 0.81 | GPR84 (0.37) | ALDH1A1DHFRKDM4EMAPTHCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019078701-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2019-04-25 | — | — | WO | disclosed |
| EP-2834321-B1 | USE OF A SEMICONDUCTING COMPOUND IN AN ORGANIC LIGHT EMITTING DEVICE | NOVALED GMBH (DE) | 2017-05-17 | — | — | EP | disclosed |
| US-20150115241-A1 | Use of a Semiconducting Compound in an Organic Light Emitting Device | NOVALED GMBH (DE) | 2015-04-30 | — | — | US | disclosed |
| US-20150115241-A1 | Use of a Semiconducting Compound in an Organic Light Emitting Device | NOVALED GMBH (DE) | 2015-04-30 | — | — | US | disclosed |
| US-20150115241-A1 | Use of a Semiconducting Compound in an Organic Light Emitting Device | NOVALED GMBH (DE) | 2015-04-30 | — | — | US | disclosed |
| EP-2834321-A1 | USE OF A SEMICONDUCTING COMPOUND IN AN ORGANIC LIGHT EMITTING DEVICE | Novaled GmbH (DE) | 2015-02-11 | — | — | EP | disclosed |
| WO-2013149958-A1 | USE OF A SEMICONDUCTING COMPOUND IN AN ORGANIC LIGHT EMITTING DEVICE | NOVALED AG (DE) | 2013-10-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150115241-A1 | Use of a Semiconducting Compound in an Organic Light Emitting Device | SLC18A3, XPOT, SLC18A2 | CYP2A6 458/4885PDK2 1675/4885ALDH1A1 1719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.